Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CHEK2 anticorps

Cet anticorps anti-CHEK2 est un anticorps Souris Monoclonal détectant CHEK2 dans WB, IF, IP et FACS. Adapté pour Humain.
N° du produit ABIN7126216

Aperçu rapide pour CHEK2 anticorps (ABIN7126216)

Antigène

Voir toutes CHEK2 Anticorps
CHEK2 (Checkpoint Kinase 2 (CHEK2))

Reactivité

  • 237
  • 87
  • 73
  • 16
  • 13
  • 7
  • 6
  • 5
  • 3
  • 2
  • 2
  • 1
Humain

Hôte

  • 217
  • 22
  • 1
Souris

Clonalité

  • 206
  • 34
Monoclonal

Conjugué

  • 111
  • 11
  • 9
  • 9
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
Cet anticorp CHEK2 est non-conjugé

Application

  • 202
  • 79
  • 78
  • 69
  • 41
  • 38
  • 31
  • 28
  • 23
  • 20
  • 18
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Immunoprecipitation (IP), Flow Cytometry (FACS)
  • Specificité

    Recognizes a serine/threonine protein kinase that is a required check-point to mediate cell cycle arrest, activation of DNA repair and apoptosis. In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. Also, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors.

    Réactivité croisée (Details)

    Human. Predicted to react with Mouse and Rat.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant fragment of human CHEK2 corresponding to protein domain

    Isotype

    IgG2b
  • Indications d'application

    Known_Application: Immunoprecipitation (1-2 μg per 100-500 μg of total protein), Flow Cytometry (1-2 μg/million cells), ,Western Blot (1-2 μg/mL),Immunofluorescence (1-2 μg/mL), ,Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa or HCT 116 cells. Human testis, spleen or colon.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    CHEK2 (Checkpoint Kinase 2 (CHEK2))

    Autre désignation

    CHEK2

    Sujet

    Cds1 homolog, Checkpoint kinase 2, Checkpoint like protein CHK2, CHK2 checkpoint homolog (S. pombe), hCds1, HuCds 1, LFS2, PP1425, RAD53, Rad53 homolog, Serine/threonine protein kinase Chk2,CHEK2
    Cellular localisation: Nucleus.

    Poids moléculaire

    60.91kDa

    ID gène

    11200, 291363, 505297

    UniProt

    O96017

    Pathways

    Signalisation p53, Apoptose, Cycle Cellulaire
Vous êtes ici:
Chat with us!